Metastatic Castration-Resistant Prostate Cancer, Immune Checkpoint Inhibitors, and Beyond
The therapeutic landscape of several genitourinary malignancies has been revolutionized by the development of immune checkpoint inhibitors (ICIs); however, the utility of immunotherapies in prostate cancer has been limited, partly due to the immunologically “cold” tumor terrain of prostate cancer. A...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
MDPI AG
2023-04-01
|
| Collection: | Current Oncology |
| Sujets: | |
| Accès en ligne: | https://www.mdpi.com/1718-7729/30/4/323 |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|